Literature DB >> 29133084

MRI for the measurement of liver iron content, and for the diagnosis and follow-up of iron overload disorders.

Anita Paisant1, Gaspard d'Assignies1, Elise Bannier1, Edouard Bardou-Jacquet1, Yves Gandon2.   

Abstract

MRI is now the reference method for detecting and quantifying hepatic and extrahepatic iron overload, regardless of its cause. The decrease of the hepatic signal is proportional to the amount of iron in the tissues. It is more pronounced with T2*-weighted gradient echo sequences. It increases proportionally with the strength of the magnetic field. Thus a 3-T MRI is be more sensitive and probably more accurate to detect a slight iron overload, as seen in dysmetabolic hepatosiderosis. Conversely, a 1.5-T MRI better estimates a high overload. Quantification can be done with the calculation of T2* (or R2*) or by using the liver to muscle signal intensity ratio (SIR). Today with a single multi-echo gradient-echo sequence, obtained in a unique apnea, the two methods can be used simultaneously. An associated quantification of steatosis is also obtained. This same type of sequence is proposed for quantification of iron in other tissues and in particular for the myocardium.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29133084     DOI: 10.1016/j.lpm.2017.10.008

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  11 in total

1.  Evaluation of liver tissue by ultrasound elastography and clinical parameters in children with multiple blood cell transfusions.

Authors:  Georg W Wurschi; Karim Kentouche; Karl-Heinz Herrmann; Ines Krumbein; Mariana Nold; James F Beck; Jürgen R Reichenbach; Hans-Joachim Mentzel
Journal:  Pediatr Radiol       Date:  2019-03-29

2.  The influence of liver fat deposition on the quantification of the liver-iron fraction using fast-kilovolt-peak switching dual-energy CT imaging and material decomposition technique: an in vitro experimental study.

Authors:  Tingting Xie; Yongbin Li; Guanyong He; Zhen Zhang; Qiao Shi; Guanxun Cheng
Journal:  Quant Imaging Med Surg       Date:  2019-04

3.  Serum Scoring and Quantitative Magnetic Resonance Imaging in Intestinal Failure-Associated Liver Disease: A Feasibility Study.

Authors:  Konstantinos C Fragkos; María Claudia Picasso Bouroncle; Shankar Kumar; Lucy Caselton; Alex Menys; Alan Bainbridge; Stuart A Taylor; Francisco Torrealdea; Tomoko Kumagai; Simona Di Caro; Farooq Rahman; Jane Macnaughtan; Manil D Chouhan; Shameer Mehta
Journal:  Nutrients       Date:  2020-07-19       Impact factor: 5.717

4.  Measurement of liver iron by magnetic resonance imaging in the UK Biobank population.

Authors:  Andy McKay; Henry R Wilman; Andrea Dennis; Matt Kelly; Michael L Gyngell; Stefan Neubauer; Jimmy D Bell; Rajarshi Banerjee; E Louise Thomas
Journal:  PLoS One       Date:  2018-12-21       Impact factor: 3.240

5.  Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study.

Authors:  Guy Rostoker; Christelle Loridon; Mireille Griuncelli; Clémentine Rabaté; Fanny Lepeytre; Pablo Ureña-Torres; Belkacem Issad; Nasredine Ghali; Yves Cohen
Journal:  EBioMedicine       Date:  2018-11-28       Impact factor: 8.143

6.  Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration.

Authors:  Henry R Wilman; Constantinos A Parisinos; Naeimeh Atabaki-Pasdar; Matt Kelly; E Louise Thomas; Stefan Neubauer; Anubha Mahajan; Aroon D Hingorani; Riyaz S Patel; Harry Hemingway; Paul W Franks; Jimmy D Bell; Rajarshi Banerjee; Hanieh Yaghootkar
Journal:  J Hepatol       Date:  2019-06-19       Impact factor: 25.083

Review 7.  Revisiting hemochromatosis: genetic vs. phenotypic manifestations.

Authors:  Gregory J Anderson; Edouard Bardou-Jacquet
Journal:  Ann Transl Med       Date:  2021-04

8.  INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis-a protocol for a prospective open-label blinded endpoint randomised controlled trial.

Authors:  Sandawana William Majoni; Jane Nelson; Darren Germaine; Libby Hoppo; Stephanie Long; Shilpa Divakaran; Brandon Turner; Jessica Graham; Sajiv Cherian; Basant Pawar; Geetha Rathnayake; Bianca Heron; Louise Maple-Brown; Robert Batey; Peter Morris; Jane Davies; David Kiran Fernandes; Madhivanan Sundaram; Asanga Abeyaratne; Yun Hui Sheryl Wong; Paul D Lawton; Sean Taylor; Federica Barzi; Alan Cass
Journal:  Trials       Date:  2021-12-02       Impact factor: 2.279

9.  Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients.

Authors:  Guy Rostoker; Fanny Lepeytre; Myriam Merzoug; Mireille Griuncelli; Christelle Loridon; Ghada Boulahia; Yves Cohen
Journal:  Pharmaceutics       Date:  2022-07-05       Impact factor: 6.525

10.  Histological Scores Validate the Accuracy of Hepatic Iron Load Measured by Signal Intensity Ratio and R2* Relaxometry MRI in Dialysis Patients.

Authors:  Guy Rostoker; Mireille Laroudie; Raphaël Blanc; Mireille Griuncelli; Christelle Loridon; Fanny Lepeytre; Clémentine Rabaté; Yves Cohen
Journal:  J Clin Med       Date:  2019-12-19       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.